Movement Alert|ILUVATAR COREX Falls 4.74% in Regular Trading, Earnings Quality Doubts Compound Semiconductor Sector Weakness

Market Focus
Sep 02

On September 2, ILUVATAR COREX fell 4.74% in regular trading, trading at HK$369.2/share, with turnover of HK$64.62 million. The decline extends a selloff triggered by market skepticism over the quality of the company's first-half earnings.

The company reported H1 revenue of RMB 946 million, up 191.6% year-over-year, with net profit of RMB 106 million marking a turnaround from a RMB 609 million loss a year earlier. However, the profit was largely underpinned by RMB 756 million in unrealized fair-value gains from its stake in a Shanghai-listed advanced packaging firm, rather than core GPU business improvement. Stripping out this non-operating item, the main business remained in loss. Meanwhile, gross margin plunged from 50.1% to 17.2%, well below industry peers, fueling investor concern over profitability sustainability.

The broader semiconductor sector added pressure, with BIREN TECH down 4.75%, HUA HONG GRACE down 2.23%, and MONTAGE TECH down 1.90%. Although ILUVATAR COREX is set to join the Hang Seng TECH Index on September 7 — with an estimated HK$6.9 billion in passive fund inflows — near-term earnings quality concerns and sector-wide selling continue to weigh on the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10